Literature DB >> 7881734

Failure of nitric oxide donors to alter arrhythmias induced by acute myocardial ischaemia or reperfusion in anaesthetized rats.

C S Barnes1, S J Coker.   

Abstract

1. The aim of the present studies was to examine the effects of nitric oxide donors on arrhythmias induced by coronary artery occlusion and reperfusion, and on cardiac cyclic nucleotides. Experiments were performed in pentobarbitone-anaesthetized rats prepared for occlusion of the left coronary artery. 2. Sodium nitroprusside (0.1, 0.3 and 1 microgram kg-1 min-1) had no significant effects on the incidence of ventricular tachycardia, total ventricular fibrillation or the mortality resulting from 25 min of acute myocardial ischaemia when compared with values in controls. In addition, there was no alteration in the number of ventricular premature beats that occurred in survivors. 3. 3-Morpholinosydnonimine-N-ethylcarbamide (SIN-1, 10, 20 and 40 micrograms kg-1 min-1) caused marked hypotension but did not alter the incidence or severity of ischaemia-induced arrhythmias. In rats subject to abrupt reperfusion after 5 min of myocardial ischaemia, lower doses of SIN-1 (1, 3 and 10 micrograms kg-1 min-1) still caused significant reductions in systolic and diastolic blood pressure but were devoid of antiarrhythmic activity. 4. In separate experiments in sham-operated rats, sodium nitroprusside (1 microgram kg-1 min-1), isosorbide dinitrate (30 and 60 micrograms kg-1 min-1) and SIN-1 (20 and 40 micrograms kg-1 min-1) had no significant effects on cardiac cyclic GMP content. 5. These results indicate that nitric oxide donors do not alter arrhythmias induced by acute coronary artery occlusion or reperfusion in anaesthetized rats. Although increases in total cardiac cyclic GMP could not be detected, the results suggest that, at least in the rat, cyclic GMP does not influence these arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7881734      PMCID: PMC1510238          DOI: 10.1111/j.1476-5381.1995.tb13233.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor.

Authors:  W Martin; R F Furchgott; G M Villani; D Jothianandan
Journal:  J Pharmacol Exp Ther       Date:  1986-05       Impact factor: 4.030

2.  Ketanserin and ritanserin can reduce reperfusion-induced but not ischaemia-induced arrhythmias in anaesthetised rats.

Authors:  S J Coker; A M Ellis
Journal:  J Cardiovasc Pharmacol       Date:  1987-10       Impact factor: 3.105

3.  Endothelium-derived relaxing factor inhibits in vitro platelet aggregation.

Authors:  B Furlong; A H Henderson; M J Lewis; J A Smith
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

4.  Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

5.  An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents.

Authors:  K A Kane; J R Parratt; F M Williams
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

6.  Effect of molsidomine on spontaneous ventricular fibrillation following myocardial ischemia and reperfusion in the dog.

Authors:  P A Martorana; A M Mogilev; B Kettenbach; R E Nitz
Journal:  Adv Myocardiol       Date:  1983

7.  Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction.

Authors:  M P Maxwell; D J Hearse; D M Yellon
Journal:  Cardiovasc Res       Date:  1987-10       Impact factor: 10.787

8.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

9.  The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion.

Authors:  M J Walker; M J Curtis; D J Hearse; R W Campbell; M J Janse; D M Yellon; S M Cobbe; S J Coker; J B Harness; D W Harron
Journal:  Cardiovasc Res       Date:  1988-07       Impact factor: 10.787

10.  Molsidomine prevents post-ischaemic ventricular fibrillation in dogs.

Authors:  J P Cano; J C Guillen; R Jouve; F Langlet; P E Puddu; P H Rolland; A Serradimigni
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

View more
  7 in total

1.  Greater antiarrhythmic activity of acute 17beta-estradiol in female than male anaesthetized rats: correlation with Ca2+ channel blockade.

Authors:  K L Philp; M Hussain; N F Byrne; M J Diver; G Hart; S J Coker
Journal:  Br J Pharmacol       Date:  2006-08-29       Impact factor: 8.739

2.  Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.

Authors:  Sarah K Walsh; Claire Y Hepburn; Kathleen A Kane; Cherry L Wainwright
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

3.  Role of nitric oxide in regulating cardiac electrophysiology.

Authors:  L Wang
Journal:  Exp Clin Cardiol       Date:  2001

4.  Modulation of gap junctions by nitric oxide contributes to the anti-arrhythmic effect of sodium nitroprusside?

Authors:  Márton Gönczi; Rita Papp; Mária Kovács; György Seprényi; Agnes Végh
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

5.  Suppression of reperfusion-induced arrhythmias with combined administration of 5-HT2 and thromboxane A2 antagonists.

Authors:  L A Shaw; S J Coker
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

6.  An endogenous protectant effect of cardiac cyclic GMP against reperfusion-induced ventricular fibrillation in the rat heart.

Authors:  R Pabla; P Bland-Ward; P K Moore; M J Curtis
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

7.  NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs.

Authors:  Cherry L Wainwright; Ashley M Miller; Lorraine M Work; Piero Del Soldato
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.